"/> Novus Biologicals™ Peptide bloquant d’anticorps SL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps SLC22A10

Réf. : BL-RE-142813Réf. fabricant : 18274299 100 μg
269,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
387775
Espèces
Human
Numéro d’adhésion
Q63ZE4
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
Lyophilized with sterile distilled water.
Marque
Novus Biologicals

A blocking peptide from human SLC22A10.

Points forts

Source

Synthetic

Amino Acid Sequence

(Accession #: NP_001034841) QTLRVALACLGIGCSAATFSSVAVHFIELIPTVLRARASGIDLTASRIGA The SLC22A10 Blocking Peptide is derived from Synthetic. The SLC22A10 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-142813
Réf. fabricant18274299
Gene ID (Entrez)387775
EspècesHuman
Numéro d’adhésionQ63ZE4
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormuleLyophilized with sterile distilled water.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-91568. This Synthetic Peptide is Designed for Use in an Antibody Competition Assay with Its Corresponding Antibody. Use of This Product in Any Other Assay Has Not Yet Been Tested. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènemember 10, solute carrier family 22, member 10
Symbole de gène(s)SLC22A10
Poids moléculaire60kDa
Type de produitSLC22A10
Quantité100 μg
État réglementaireRUO - research use only
Une question, une configuration particulière ?
Contactez-nous pour un devis.